Shraga-Heled N - Search Results

1

Semaphorin-3F is an inhibitor of tumor angiogenesis.

Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, Baruch L, Machluf M, Neufeld G. Kessler O, et al. Among authors: shraga heled n. Cancer Res. 2004 Feb 1;64(3):1008-15. doi: 10.1158/0008-5472.can-03-3090. Cancer Res. 2004. PMID: 14871832

2

The neuropilins and their role in tumorigenesis and tumor progression.

Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G. Guttmann-Raviv N, et al. Among authors: shraga heled n. Cancer Lett. 2006 Jan 8;231(1):1-11. doi: 10.1016/j.canlet.2004.12.047. Cancer Lett. 2006. PMID: 16356825 Review.

3

Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Guttmann-Raviv N, et al. Among authors: shraga heled n. J Biol Chem. 2007 Sep 7;282(36):26294-305. doi: 10.1074/jbc.M609711200. Epub 2007 Jun 14. J Biol Chem. 2007. PMID: 17569671 Free article.

4

Semaphorins in cancer.

Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, Kessler O. Neufeld G, et al. Among authors: shraga heled n. Front Biosci. 2005 Jan 1;10:751-60. doi: 10.2741/1569. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569615 Review.

5

Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.

Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. Shraga-Heled N, et al. FASEB J. 2007 Mar;21(3):915-26. doi: 10.1096/fj.06-6277com. Epub 2006 Dec 21. FASEB J. 2007. PMID: 17185751

6

Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Prahst C, Héroult M, Lanahan AA, Uziel N, Kessler O, Shraga-Heled N, Simons M, Neufeld G, Augustin HG. Prahst C, et al. Among authors: shraga heled n. J Biol Chem. 2008 Sep 12;283(37):25110-25114. doi: 10.1074/jbc.C800137200. Epub 2008 Jul 15. J Biol Chem. 2008. PMID: 18628209 Free PMC article.

7

Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.

Allen H, Shraga-Heled N, Blumenfeld M, Dego-Ashto T, Fuchs-Telem D, Gilert A, Aberman Z, Ofir R. Allen H, et al. Among authors: shraga heled n. Sci Rep. 2018 Jan 12;8(1):670. doi: 10.1038/s41598-017-18428-1. Sci Rep. 2018. PMID: 29330447 Free PMC article.

8

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications.

Betzer O, Meir R, Dreifuss T, Shamalov K, Motiei M, Shwartz A, Baranes K, Cohen CJ, Shraga-Heled N, Ofir R, Yadid G, Popovtzer R. Betzer O, et al. Among authors: shraga heled n. Sci Rep. 2015 Oct 28;5:15400. doi: 10.1038/srep15400. Sci Rep. 2015. PMID: 26507853 Free PMC article.

9

Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model.

Pe'er-Nissan H, Ahdoot-Levi H, Betzer O, Itzhak PS, Shraga-Heled N, Gispan I, Motiei M, Doroshev A, Anker Y, Popovtzer R, Ofir R, Yadid G. Pe'er-Nissan H, et al. Among authors: shraga heled n. Pharmaceutics. 2022 Jun 21;14(7):1311. doi: 10.3390/pharmaceutics14071311. Pharmaceutics. 2022. PMID: 35890207 Free PMC article.

10

Prostaglandin receptor EP₁-mediated differential degradation of cyclooxygenases involves a specific lysine residue.

Spector-Chotiner A, Shraga-Heled N, Sood R, Rimon G, Barki-Harrington L. Spector-Chotiner A, et al. Among authors: shraga heled n. Biochem Biophys Res Commun. 2014 Jan 10;443(2):738-42. doi: 10.1016/j.bbrc.2013.12.038. Epub 2013 Dec 12. Biochem Biophys Res Commun. 2014. PMID: 24333447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters